What is Novos?
Founded in 2018 and headquartered in New York City, Novos operates at the intersection of biotechnology and consumer wellness. The company distinguishes itself through a research-first methodology, providing consumers with nutraceuticals formulated based on the latest scientific discoveries in the field of aging and cellular health. By leveraging data-driven insights, Novos aims to bridge the gap between academic longevity research and accessible, high-quality health products. Their market position is defined by a commitment to transparency and efficacy, catering to a growing demographic of health-conscious consumers seeking evidence-based interventions to extend their healthy lifespans.
How much funding has Novos raised?
Novos has raised a total of $3.1M across 1 funding round:
Unspecified
$3.1M
Unspecified (2021): $3.2M with participation from Arkitekt Ventures, Awesome People Ventures, Resolute.Vc, and Longevitytech.Fund
Key Investors in Novos
Arkitekt Ventures
Arkitekt Ventures is an early stage venture fund that focuses on innovative healthcare delivery models and the application of frontier technology in medicine.
Awesome People Ventures
Awesome People Ventures is an investment firm focused on supporting exceptional founders at the pre-seed and seed stages, specializing in innovative projects.
Resolute.Vc
Resolute Ventures supports founders at the beginning of their entrepreneurial journey by leading pre-seed and seed funding rounds with a focus on health and wellness.
What's next for Novos?
With the recent influx of capital, Novos is poised to enter a new phase of enterprise-level growth. The strategic roadmap likely involves expanding its product portfolio, deepening its research capabilities, and enhancing its distribution channels to reach a broader global audience. As the longevity market continues to mature, the company's focus on scientific rigor will be critical in maintaining its competitive advantage. Future initiatives will likely center on clinical validation and the integration of advanced health-tech solutions to further personalize the consumer experience, ensuring that Novos remains at the forefront of the longevity revolution.
See full Novos company page
